HomeCompareLETB vs JNJ

LETB vs JNJ: Dividend Comparison 2026

LETB yields 8.76% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LETB wins by $15.7K in total portfolio value
10 years
LETB
LETB
● Live price
8.76%
Share price
$22.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.7K
Annual income
$1,522.31
Full LETB calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — LETB vs JNJ

📍 LETB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLETBJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LETB + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LETB pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LETB
Annual income on $10K today (after 15% tax)
$744.47/yr
After 10yr DRIP, annual income (after tax)
$1,293.96/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, LETB beats the other by $590.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LETB + JNJ for your $10,000?

LETB: 50%JNJ: 50%
100% JNJ50/50100% LETB
Portfolio after 10yr
$27.9K
Annual income
$1,175.04/yr
Blended yield
4.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LETB
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LETB buys
0
JNJ buys
0
No recent congressional trades found for LETB or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLETBJNJ
Forward yield8.76%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$35.7K$20.0K
Annual income after 10y$1,522.31$827.78
Total dividends collected$12.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LETB vs JNJ ($10,000, DRIP)

YearLETB PortfolioLETB Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,576$875.85$10,676$355.77+$900.00LETB
2$13,334$947.54$11,407$389.39+$1.9KLETB
3$15,287$1,020.03$12,198$426.53+$3.1KLETB
4$17,450$1,092.96$13,056$467.62+$4.4KLETB
5$19,838$1,165.98$13,987$513.12+$5.9KLETB
6$22,465$1,238.80$14,998$563.56+$7.5KLETB
7$25,349$1,311.09$16,098$619.52+$9.3KLETB
8$28,506$1,382.61$17,295$681.69+$11.2KLETB
9$31,954$1,453.08$18,599$750.82+$13.4KLETB
10$35,713$1,522.31$20,022$827.78+$15.7KLETB

LETB vs JNJ: Complete Analysis 2026

LETBStock

The fund is an actively managed ETF that invest in U.S. exchange listed equities, primarily consisting of common stock of large-, mid- and small-capitalization companies. The adviser typically holds positions in each of these three market capitalizations and the allocation of assets to each individual stock within each market capitalization is typically equal weighted. The investment advisor allocates the fund’s portfolio investments using research obtained from Let Bob, LLC, a smart-charting platform that incorporates fundamental and technical analysis with modern artificial intelligence capabilities.

Full LETB Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this LETB vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LETB vs SCHDLETB vs JEPILETB vs OLETB vs KOLETB vs MAINLETB vs ABBVLETB vs MRKLETB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.